Dysplasia in inflammatory bowel diseases: Definition and clinical impact

Canadian Journal of Gastroenterology

Volumn 13, Issue 8, 1999, Pages 671-678

  Geboes, Karel ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dysplasia; Inflammatory bowel disease

Indexed keywords

CYTOKERATIN; DNA; PROTEIN P53;

ADENOMA; BIOPSY; CANCER RISK; CELL DEATH; CELL PROLIFERATION; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; ENTERITIS; GENETIC DISORDER; HUMAN; INTESTINE CANCER; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 0033370295     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/124190     Document Type: Review

References (44)

1. Bargen JA. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928;17:561-76.
2. Dawson IMP, Pryse-Davies J. The development of carcinoma in the large intestine in ulcerative colitis. Br J Surg 1959;47:113-28.
3. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
4. Boley S, Brandt LJ. Vascular ectasias of the colon. Dig Dis Sci 1986;31:26S-42S.
5. Jass JR, Sobin LH. Histological Typing of Intestinal Tumours, 2nd edn. Berlin: Springer Verlag, 1989:2-3.
6. Harnden DG, McGee JOD. Neoplasia. In: McGee JOD, Isaacson PG, Wright NA, eds. Oxford Textbook of Pathology, vol 1. Oxford: Oxford University press, 1992:571-89.
7. Henrikson CK, Argenzio RA, Liacos JA, Khosla J. Morphologic and functional effects of bile salt on the porcine colon during injury and repair. Lab Invest 1989;60:72-87.
8. Ming SCH, Bajtai A, Correa P, et al. Gastric dysplasia: significance and pathologic criteria. Cancer 1984;54:1794-1801.
9. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980;33:711-21.
10. Oehlert W, Keller P, Henke M, Strauch M. Die Dysplasien der Magenschleimhaut. Dtsch Med Wochenschr 1975;100:1950-6.
11. Riddel RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
12. Melville DM, Jass JR, Shepherd NA, et al. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology 1988;95:668-75.
13. Dobbins WO III. Dysplasia and malignancy in inflammatory bowel disease. Annu Rev Med 1984;35:33-48.
14. Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
15. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful surveillance program of patients with ulcerative colitis. Gastroenterology 1995;108:1361-70.
16. Blackstone MO, Riddell RH, Rogers BHG, Levin B. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis. An indication for colectomy. Gastroenterology 1981;80:366-74.
17. Torres C, Antonioli D, Odze R. Polypoid dysplasia and adenomas in inflammatory bowel disease. Am J Surg Pathol 1998;22:275-84.
18. Stolte M, Schneider A. Differential diagnosis of adenomas and dysplasias in patients with ulcerative colitis. In: Tytgat GNJ, Bartelsman JFWM, van Deventer SJH, eds. Inflammatory Bowel Diseases. Dordrecht: Kluwer Academic Publishers, 1995:133-44.
19. Hyde GM, Warren BF, Jewell DP. Histological changes following intravenous cyclosporin in the treatment of refractory severe ulcerative colitis may mimic dysplasia. Gut 1998;42:A43. (Abst)
20. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
21. Löfberg R, Broström O, Karlen P, Tribukait B, Öst A. Colonoscopic surveillance in longstanding total ulcerative colitis - a fifteen year follow-up study. Gastroenterology 1990;99:1021-31.
22. Löfberg R, Befrits R, Sjöqvist U, et al. Colorectal cancer in Crohn's disease - high frequency of DNA-aneuploidy. Gut 1996;39:A165. (Abst)
23. Rubin CE, Haggit RC, Burmer C, et al. DNA-aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
24. Karlen P, Löfberg R, Broström O, Tribukait B. Absolute cumulative risk of developing DNA-aneuploidy in longstanding ulcerative colitis. Gastroenterology 1993;104:A720. (Abst)
25. Suzuki H, Harpaz N, Tarmin L, et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasia and cancers. Cancer Res 1994;54:4841-4.
26. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-ki-ras mutations in ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990;99:416-20.
27. Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c-Ki-ras mutations in dysplastic fields and cancer in ulcerative colitis. Gastroenterology 1992;102:1983-7.
28. Tarmin L, Yin J, Harpaz N, et al. APC gene mutations in ulcerative colitis associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995;55:2035-8.
29. Burmer GC, Rabinovitch PS, Haggitt RC, et al. Neoplastic progression in ulcerative colitis: Histology, DNA content and loss of p53 allele. Gastroenterology 1992;103:1602-10.
30. Jones DR, Davidson AG, Summers CL, Murray GF, Quinlan DC. Potential application of p53 as an intermediate biomarker in Barrett's esophagus. Ann Thorac Surg 1994;57:598-603.
31. Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 1995;19:1418-22.
32. Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
33. Caulin C, Bauluz C, Gandarillas A, et al. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes. Exp Cell Res 1992;204:11-21.
34. Viaene A, Baert J, Lerut T, Geboes K. In situ hybridisation: a versatile tool to localise gene-expression on tissue sections. Acta Endosc 1997;27:117-27.
35. Geboes K, Rutgeerts P. CD44v6 and CD44v3 variants in inflammatory bowel disease. Lancet 1995;345:1191-2.
36. Mulder JWR, Wielenga VJM, Polak MM, et al. Expression of mutant p53 and CD44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80.
37. Rosenberg WMC, Prince C, Kaklamanis L, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 1995;345:1205-9.
38. Fromont-Hankard G, Cezard JP, Aigrain Y, Navarro J, Peuchmaur M. CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased cell proliferation. Histopathology 1998;32:317-21.
39. Karagiannakis AJ, Syrigos KN, Efstathion J, et al. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J Pathol 1998;185:413-8.
40. Ilyas M, Tomlinson IP, Hanby A, Talbot IC, Bodmer WF. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 1997;40:654-9.
41. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985;89:398-407.
42. Talbot IC. Dysplasia in the gastrointestinal tract: significance, terminology and diagnosis. Acta Endosc 1996;26:119-24.
43. Foucar E. Do pathologists play dice? Uncertaintly and early histopathological diagnosis of common malignancies. Histopathology 1997;31:495-502.
44. Ilyas M, Tomlinson IPM. Genetic pathways in colorectal cancer. Histopathology 1996;28:389-99.